Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD

P O Stotzer1, L Blomberg, P L Conway

  • 1Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg, Sweden.

Insights

Oral Lactobacillus fermentum KLD did not significantly improve symptoms or breath test results for small intestinal bacterial overgrowth. Further research is needed to explore probiotic efficacy for this condition.

Area of Science:

  • Microbiology
  • Gastroenterology
  • Clinical Medicine

Background:

  • Probiotics, specifically harmless bacteria like Lactobacillus, have a history of use in managing gastrointestinal issues.
  • Previous applications include prophylaxis against traveler's diarrhea and treatment for recurrent C. difficile infections.

Purpose of the Study:

  • To investigate the efficacy of oral Lactobacillus fermentum KLD in treating chronic small intestinal bacterial overgrowth (SIBO).

Main Methods:

  • A double-blind, placebo-controlled, cross-over study involving 17 patients with SIBO.
  • Patients received either Lactobacillus fermentum KLD or placebo orally twice daily for 4-week periods, separated by a 4-week washout.
  • Diagnosis and efficacy were assessed using glucose hydrogen breath tests and symptom scoring.

Main Results:

  • No significant differences were observed between Lactobacillus fermentum KLD and placebo groups in hydrogen breath test results (29 vs 14 ppm).
  • Stool frequency (14 vs 12 defecations/week) and symptom scores (12 vs 17 scores/week) also showed no significant improvement with probiotic treatment.
  • High levels of L. fermentum KLD were detected in fecal samples of only 2 out of 14 completing patients.

Conclusions:

  • Oral administration of Lactobacillus fermentum KLD did not demonstrate significant efficacy in altering key parameters for small intestinal bacterial overgrowth in this study.
  • The findings suggest that this specific probiotic strain and dosage may not be effective for treating SIBO.
  • Further investigation into optimal probiotic strains, dosages, and patient selection is warranted for SIBO management.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
Microbes in the Production of Fermented Foods01:27

Microbes in the Production of Fermented Foods

Lactic acid bacteria (LAB) and molds are instrumental in fermenting plant-based foods to enhance preservation and ensure year-round availability. These microbial processes convert plant carbohydrates into organic acids and other metabolites that inhibit spoilage organisms and contribute to the sensory qualities of the final product.In sauerkraut production, cabbage goes through a microbial succession that starts with cocci such as Leuconostoc mesenteroides. These microbes begin fermentation by...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...